The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody is a polyclonal antibody designed to detect the post-translational 2-hydroxyisobutyryl modification at lysine 18 (K18) of the histone H3.1 protein encoded by the HIST1H3A gene. This modification is part of the broader epigenetic regulatory mechanisms influencing chromatin structure and gene expression .
Target Protein: Histone H3.1 (HIST1H3A)
Modification: 2-hydroxyisobutyrylation at K18
Species Reactivity: Human (Homo sapiens)
Host Species: Rabbit
Isotype: IgG
Validated for use in multiple experimental workflows:
Western Blot: Shows a single band at 16 kDa in HeLa, Jurkat, 293, and HepG2 lysates under sodium butyrate treatment .
Immunocytochemistry (ICC): Nuclear staining pattern confirmed in fixed/permeabilized HeLa cells using a Leica BondTM system .
Specificity: No cross-reactivity with acetyl-K18 (ab1191) or other histone H3 modifications (e.g., acetyl-K9, acetyl-K27) .
Epigenetic Regulation: K18 modifications (e.g., acetylation, lactylation, 2-hydroxyisobutyrylation) modulate DNA accessibility and transcriptional activity .
Disease Relevance: H3K18 lactylation is implicated in septic shock pathogenesis, suggesting a potential regulatory link between metabolic states and chromatin remodeling .
Storage: Stable at -20°C in 50% glycerol, 0.01M PBS (pH 7.4) with 0.03% Proclin 300 .
Limitations: For research use only. Not validated for diagnostic applications .
This antibody enables studies on:
Lysine 2-hydroxyisobutyrylation (Khib) is a post-translational modification derived from 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA. Unlike more common modifications such as acetylation or methylation, Khib has a unique chemical structure and specific genomic distribution patterns. This modification has been shown to be associated with active gene expression, particularly in spermatogenic cells. The modification exhibits varied dynamics among diverse model systems and appears to be mechanistically and functionally distinct from histone lysine acetylation (Kac) and methylation (Kme) . The unique regulatory function of this modification is linked to two cellular metabolites: 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA, which serve as precursors for this PTM .
The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody is a polyclonal antibody raised in rabbits that specifically recognizes the 2-hydroxyisobutyryl modification at lysine 18 of histone H3.1. The immunogen used for producing this antibody is a peptide sequence surrounding the site of 2-hydroxyisobutyryl-Lys (18) derived from Human Histone H3.1 . This antibody is purified through antigen affinity methods and is designed to be highly specific for the modified lysine residue, allowing researchers to detect and quantify this specific post-translational modification in experimental settings .
Structural modeling has revealed important insights about enzyme interaction with 2-hydroxyisobutyryl-CoA. For example, studies of Esa1p (a yeast acetyltransferase) bound to acetyl-CoA showed that its catalytic pocket is large enough to accommodate 2-hydroxyisobutyryl-CoA with its larger acyl tail. When researchers modeled an Esa1p/2-hydroxyisobutyryl-CoA structure based on the acetyl-CoA-bound Esa1p structure, they found that 2-hydroxyisobutyryl-CoA binds in a similar manner, with the 2-hydroxyisobutyryl group fitting well into the catalytic pocket . This structural compatibility explains how enzymes like Esa1p and its human homolog Tip60 can catalyze 2-hydroxyisobutyrylation despite their primary evolution as acetyltransferases .
The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody has been validated for multiple experimental applications, including:
Enzyme-Linked Immunosorbent Assay (ELISA)
Western Blotting (WB)
Immunocytochemistry (ICC)
Immunofluorescence (IF)
These diverse applications make the antibody versatile for different research questions, from protein detection and quantification to localization studies and analysis of chromatin interactions . The broad application spectrum highlights the antibody's utility in both biochemical and cell-based assays.
When designing ChIP experiments with the 2-hydroxyisobutyryl-HIST1H3A (K18) antibody, researchers should consider:
Cross-linking protocol: Standard formaldehyde fixation (1% for 10 minutes) is typically sufficient for histone modifications.
Sonication conditions: Aim for chromatin fragments of 200-500 bp for optimal resolution.
Antibody concentration: Start with manufacturer's recommended dilution, typically around 1:200 for immunoprecipitation.
Controls: Include:
Input DNA (pre-immunoprecipitation sample)
IgG control (non-specific rabbit IgG)
Positive control (antibody against a well-characterized histone mark)
Validation: Consider parallel ChIP-qPCR of known regions before proceeding to sequencing.
This approach leverages the antibody's specificity for the 2-hydroxyisobutyryl modification at K18 of histone H3 and enables mapping of this modification across the genome to identify associated regulatory elements .
For optimal detection of 2-hydroxyisobutyryl-HIST1H3A (K18) in Western blots, researchers should:
Extract histones using acid extraction:
Lyse cells in Triton Extraction Buffer (PBS with 0.5% Triton X-100, 2mM PMSF, 0.02% NaN₃)
Resuspend nuclei in 0.2N HCl
Incubate overnight at 4°C
Collect supernatant containing histones
Include deacetylase inhibitors in all buffers:
Add sodium butyrate (5-30 mM) to preserve butyrl modifications
Include trichostatin A (TSA) for class I and II HDAC inhibition
Gel electrophoresis conditions:
Use 15-18% SDS-PAGE for optimal histone separation
Load 10-20 μg of acid-extracted histones
Antibody incubation:
Dilute primary antibody at 1:2000 in 1% BSA
Incubate overnight at 4°C for optimal binding
This protocol is based on successful detection of similar histone modifications and has been shown to effectively preserve the 2-hydroxyisobutyryl modification during extraction .
Distinguishing between 2-hydroxyisobutyrylation and other acylation marks requires careful experimental design:
Antibody specificity validation:
Perform peptide competition assays with modified and unmodified peptides
Use dot blots with various modified peptides to test cross-reactivity
Conduct Western blots with samples enriched for different modifications
Mass spectrometry approaches:
Use LC-MS/MS with collision-induced dissociation (CID) or electron transfer dissociation (ETD)
Analyze fragment ion patterns for diagnostic ions specific to 2-hydroxyisobutyrylation
Employ targeted multiple reaction monitoring for specific modified peptides
Parallel immunoprecipitations:
Compare ChIP-seq profiles of 2-hydroxyisobutyrylation with other marks like butyrylation or acetylation
Analyze co-occurrence patterns and unique genomic distributions
Research shows that H4K8hib has unique genomic distribution patterns compared to acetylation and methylation marks, supporting the distinction between these modifications . Mass spectrometry has identified H4K8, H4K12, H4K16, and H4K31 as K2hib substrates of Tip60, providing analytical targets for differentiation .
Enzyme Type | Name | Organism | Activity | Detection Method |
---|---|---|---|---|
Writers | Esa1p | Yeast | Adds K2hib to histones | In vitro assay with NCPs |
Tip60 | Human | Adds K2hib to H4K8, H4K12, H4K16, H4K31 | Mass spectrometry | |
Erasers | HDAC2 | Human | Removes K2hib | Knockout/overexpression |
HDAC3 | Human | Removes K2hib | Knockdown/overexpression | |
HDAC1 | Human | Marginal activity | In vitro screening |
To study these enzymes:
For writers (Esa1p/Tip60):
Use in vitro assays with purified enzymes and nucleosome core particles
Supply 2-hydroxyisobutyryl-CoA as donor
Use specific inhibitors like TH1834 for Tip60 to confirm activity
Employ genetic approaches (knockdown/overexpression)
For erasers (HDAC2/HDAC3):
Use in vitro screening with core histones as substrates
Apply HDAC inhibitors (NaBu, TSA) to confirm specificity
Implement genetic approaches (SILAC quantification after HDAC manipulation)
The search results show that overexpression of HDAC2 or HDAC3 reduced global histone K2hib levels by approximately 30%, while double depletion of HDAC2 and HDAC3 significantly increased global K2hib levels .
2-hydroxyisobutyrylation levels are influenced by multiple cellular pathways:
Metabolic pathways:
2-hydroxyisobutyrate production is linked to symbiotic gut microbiota metabolism
Cellular concentrations of 2-hydroxyisobutyryl-CoA affect modification rates
The dynamics of these metabolites are associated with diverse host metabolic phenotypes
Enzymatic regulation:
Tip60 acetyltransferase complex activity is regulated by cellular signaling
HDAC2/3 activity responds to various cellular conditions and signaling events
The balance between writer and eraser activities determines steady-state levels
Transcriptional activation:
H4K8hib is associated with regions of active gene transcription
The modification is dynamically regulated during meiotic and post-meiotic processes
Experimental approaches to study these pathways include metabolite supplementation (e.g., sodium butyrate treatment), enzyme inhibition studies, and genetic manipulation of writers and erasers in combination with transcriptional analysis . Studies have shown that treatment with 30 mM sodium butyrate for 4 hours can significantly alter histone modification patterns in HeLa and Jurkat cell lines .
Common pitfalls and solutions include:
Low signal intensity:
Increase antibody concentration (try 1:100 - 1:500 dilution)
Extend primary antibody incubation time (overnight at 4°C)
Pre-treat samples with HDAC inhibitors (sodium butyrate, TSA) to preserve modifications
Use enhanced detection systems for Western blots (e.g., biotin-streptavidin amplification)
High background or non-specific binding:
Increase blocking time and concentration (5-10% normal serum)
Include additional washing steps with higher detergent concentration
Pre-absorb antibody with unmodified histone peptides
Use more stringent antibody dilution buffers (1% BSA with 0.1% Tween-20)
Inconsistent results between replicates:
Standardize cell culture conditions affecting metabolism
Control fixation and permeabilization parameters carefully
Ensure consistent sample processing times to prevent modification loss
Use internal controls (total H3 detection) for normalization
Research protocols show that successful immunostaining involves fixation in 4% formaldehyde, permeabilization with 0.2% Triton X-100, and blocking with 10% normal goat serum for 30 minutes at room temperature .
Interpreting changes in 2-hydroxyisobutyryl-HIST1H3A (K18) levels requires consideration of:
Baseline modification levels:
Establish normal ranges in your experimental system
Compare to other histone modifications (acetylation, methylation) at similar residues
Determine cell-type specificity of the modification
Context-dependent interpretation:
Increased levels may indicate:
Enhanced gene activation (as Khib is associated with active transcription)
Metabolic changes affecting 2-hydroxyisobutyryl-CoA availability
Decreased activity of eraser enzymes (HDAC2/HDAC3)
Decreased levels may suggest:
Reduced transcriptional activity
Metabolic shifts away from 2-hydroxyisobutyrate production
Increased eraser enzyme activity
Integrated analysis:
Correlate with transcriptomic data to link modifications to gene expression
Compare with ChIP-seq data of transcription factors and other histone marks
Analyze in context of metabolomic data when possible
Research has shown that 2-hydroxyisobutyrylation has distinct genomic distribution patterns compared to acetylation and functions in regulating gene expression, particularly in spermatogenic cells . SILAC quantification studies have demonstrated that HDAC3 overexpression can decrease Khib levels by approximately 30%, providing benchmarks for expected changes .
The current understanding of the 2-hydroxyisobutyryl proteome reveals:
Scope and distribution:
Global profiling has identified 6,548 Khib sites on 1,725 substrate proteins in mammalian cells
The modification extends far beyond histones to various cellular proteins
The extensive nature of this modification suggests broad regulatory roles
Functional protein categories:
Khib-modified proteins are involved in diverse cellular processes
The modification appears on both nuclear and cytoplasmic proteins
Functional clustering reveals enrichment in specific biological pathways
Substrate specificity patterns:
Analysis of flanking sequences around Khib sites reveals potential consensus motifs
Structural analysis indicates accessibility factors for modification sites
Comparison with other acylation sites shows both overlap and unique targets
This comprehensive modification landscape provides a foundation for understanding the broader biological functions of 2-hydroxyisobutyrylation and opens new avenues for investigating how cellular metabolites influence protein function .
The coordination between 2-hydroxyisobutyryl modification and other histone marks involves:
Understanding these coordination patterns is crucial for deciphering the histone code and the specific role of 2-hydroxyisobutyrylation within this complex regulatory system . Research has shown that H4K8hib marks are associated with regions of active gene transcription in both meiotic and post-meiotic cells, suggesting a specific role in gene regulation during these developmental processes .
Emerging experimental approaches for studying metabolic regulation include:
Metabolite tracing studies:
Isotope-labeled 2-hydroxyisobutyrate to track metabolic incorporation
Metabolomic profiling combined with histone modification analysis
Microbiome manipulation to alter 2-hydroxyisobutyrate production
Advanced enzyme assays:
Development of fluorescent or bioluminescent reporters for real-time transferase activity
High-throughput screening for novel writers and erasers
Structure-guided design of specific inhibitors for functional studies
Integrated multi-omics:
Combined analysis of metabolomics, proteomics, and transcriptomics data
Correlation of gut microbiome profiles with host 2-hydroxyisobutyrylation patterns
Mathematical modeling of metabolite-modification relationships
Research has established connections between symbiotic gut microbiota-associated metabolites, including 2-hydroxyisobutyrate, and diverse host metabolic phenotypes, suggesting complex regulation of this modification pathway . The dynamics of these metabolites influence 2-hydroxyisobutyrylation levels, opening new avenues for investigating how microbial communities might influence host epigenetics through this modification pathway .